New obesity pharmacotherapies, including GLP-1 receptor agonists and combinations of entero-pancreatic hormones, show promise in achieving significant weight loss, potentially rivaling bariatric surgery’s effectiveness.
Details of New Ob/Gyn Residency Application System Revealed
Last summer, ob/gyn residency programs announced they were switching to an independent system for the 2024/2025 application season. Today, the American College of Obstetricians and